loader image
Monday, December 22, 2025
73.4 F
McAllen
- Advertisement -

Evidence shows Coffee drinkers have a lower risk of liver diseases

Translate to Spanish or other 102 languages!

Regular coffee drinkers have better liver health, a new review finds. Image for illustration purposes
Regular coffee drinkers have better liver health, a new review finds. Image for illustration purposes
- Advertisement -

MEDICAL NEWS TODAY

An expansive new review published in Biochemical Pharmacology. adds to existing evidence that drinking coffee regularly can help protect and even restore the health of one’s liver by inhibiting scarring and inflammation.

In addition to affirming previously noted associations between coffee and liver health, the review identifies potential molecular pathways that explain these beneficial relationships.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/coffee-lower-risk-liver-diseases?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-09-29&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS’ “South Texas Healthy Living” Dedicates Episode to Colon Health, Dec. 28th

It may come as a surprise, but colon health is a vital part of your overall well-being; it profoundly impacts nearly every system in the body.

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

Mega Doctor News For Isaac Garza, it’s better to give than to receive during the...

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.
- Advertisement -
×